TrialCancer medicine2020

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.

Tomohiro Enokida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.